Agafonova Nataliya has filed 17 insider transactions across 1 company since July 2023.
Most recent transaction: a tax payment of 13145 shares of Longeveron Inc. ($LGVN) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 13145 | $1.12 | 203,419.0000 | 18,373,198,000 | 6.07% | 0.00% |
| Jan. 2, 2026 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 10250 | $0.59 | 216,564.0000 | 18,373,198,000 | 4.52% | 0.00% |
| Oct. 1, 2025 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 11883 | $0.74 | 226,814.0000 | 18,373,198,000 | 4.98% | 0.00% |
| July 15, 2025 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | A | Class A Common Stock | 102000 | $0.00 | 238,697.0000 | 9,411,164,000 | 74.62% | 0.00% |
| July 15, 2025 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | A | Stock Option (right to buy) | 34000 | $0.00 | 34,000.0000 | 9,411,164,000 | 9999.99% | 0.00% |
| July 1, 2025 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 7431 | $1.28 | 136,697.0000 | 9,411,164,000 | 5.16% | 0.00% |
| April 1, 2025 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 7566 | $1.50 | 144,128.0000 | 9,411,164,000 | 4.99% | 0.00% |
| Jan. 2, 2025 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 6120 | $1.79 | 151,694.0000 | 9,411,164,000 | 3.88% | 0.00% |
| Oct. 1, 2024 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 5316 | $1.88 | 157,814.0000 | 13,627,793,000 | 3.26% | 0.00% |
| Aug. 15, 2024 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | A | Stock Option (right to buy) | 16250 | $0.00 | 16,250.0000 | 2,173,490,000 | 9999.99% | 0.00% |
| Aug. 15, 2024 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 14391 | $2.46 | 163,130.0000 | 2,173,490,000 | 8.11% | 0.00% |
| Aug. 15, 2024 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | A | Class A Common Stock | 175750 | $0.00 | 177,521.0000 | 2,173,490,000 | 9923.77% | 0.01% |
| May 2, 2024 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Class A Common Stock | 308 | $2.83 | 1,771.0000 | 2,173,490,000 | 14.81% | 0.00% |
| Jan. 2, 2024 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Common Stock | 3074 | $1.32 | 20,786.0000 | 2,173,490,000 | 12.88% | 0.00% |
| Oct. 2, 2023 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Common Stock | 3059 | $2.29 | 23,860.0000 | 0 | 11.36% | 0.00% |
| Aug. 18, 2023 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | F | Common Stock | 3081 | $3.36 | 26,919.0000 | 0 | 10.27% | 0.00% |
| July 24, 2023 | Longeveron Inc. | $LGVN | Agafonova Nataliya | Chief Medical Officer | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |